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Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular
dysfunction during diet-induced obesity
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A B S T R A C T
Background: Protein kinase G (PKG) Iα is the end-eﬀector kinase that mediates nitric oxide (NO)-dependent and
oxidant-dependent vasorelaxation to maintain blood pressure during health. A hallmark of cardiovascular dis-
ease is attenuated NO production, which in part is caused by NO Synthase (NOS) uncoupling, which in turn
increases oxidative stress because of superoxide generation. NOS uncoupling promotes PKG Iα oxidation to the
interprotein disulﬁde state, likely mediated by superoxide-derived hydrogen peroxide, and because the NO-
cyclic guanosine monophosphate (cGMP) pathway otherwise negatively regulates oxidation of the kinase to its
active disulﬁde dimeric state. Diet-induced obesity is associated with NOS uncoupling, which may in part
contribute to the associated cardiovascular dysfunction due to exacerbated PKG Iα disulﬁde oxidation to the
disulﬁde state. This is a rational hypothesis because PKG Iα oxidation is known to signiﬁcantly contribute to
heart failure that arises from chronic myocardial oxidative stress.
Methods and results: Bovine arterial endothelial cells (BAECs) or smooth muscle cells (SMCs) were exposed to
drugs that uncouple NOS. These included 1,3-bis(2-chloroethyl)−1-nitrosourea (BCNU) which promotes its S-
glutathiolation, 4-diamino-6-hydroxy-pyrimidine (DAHP) which inhibits guanosine-5′-triphosphate-cyclohy-
drolase 2 to prevent BH4 synthesis or methotrexate (MTX) which inhibits the regeneration of BH4 from BH2 by
dihydrofolate reductase. While all the drugs mentioned above induced robust PKG Iα disulﬁde dimerization in
cells, exposure of BAECs to NOS inhibitor L-NMMA did not. Increased PKG Iα disulﬁde formation occurred in
hearts and aortae from mice treated in vivo with DAHP (10 mM in a drinking water for 3 weeks). Redox-dead
C42S PKG Iα knock-in (KI) mice developed less pronounced cardiac posterior wall hypertrophy and did not
develop cardiac dysfunction, assessed by echocardiography, compared to the wild-type (WT) mice after chronic
DAHP treatment. WT or KI mice were then subjected to a diet-induced obesity protocol by feeding them with a
high fat Western-type diet (RM 60% AFE) for 27 weeks, which increased body mass, adiposity, plasma leptin,
resistin and glucagon levels comparably in each genotype. Obesity-induced hypertension, assessed by radio-
telemetry, was mild and transient in the WT, while the basally hypertensive KI mice were resistant to further
increases in blood pressure following high fat feeding. Although the obesogenic diet caused mild cardiac dys-
function in the WT but not the KI mice, gross changes in myocardial structure monitored by echocardiography
were not apparent in either genotype. The level of cyclic guanosine monophosphate (cGMP) was decreased in
the aortae of WT and KI mice following high fat feeding. PKG Iα oxidation was not evident in the hearts of WT
mice fed a high fat diet.
Conclusions: Despite robust evidence for PKG Iα oxidation during NOS uncoupling in cell models, it is unlikely
that PKG Iα oxidation occurs to a signiﬁcant extent in vivo during diet-induced obesity and so is unlikely to
mediate the associated cardiovascular dysfunction.
1. Introduction
A global obesity pandemic, resulting at least in part from altered
dietary practices and a decline in physical activity, continues to emerge.
Whilst developmental programming and genetic predisposition inﬂu-
ence the propensity for obesity [1], a diet high in calories is a major
determinant. Obesity is an established risk factor for type-2 diabetes,
cancer and cardiovascular diseases [2]. In terms of the cardiovascular
system, obesity is associated with atherosclerosis [3], blood vessel
dysregulation and hypertension [4], as well as maladaptive changes to
the myocardium that alters its structure and compromises its function
[5,6].
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Protein kinase G (PKG) is the end-eﬀector kinase that mediates ni-
tric oxide (NO)-dependent vasorelaxation [7], with the Iα isoform
mediating oxidant-dependent vasorelaxation to maintain normal
healthy blood pressure [8,9] and regulate diastolic relaxation [10].
Whilst these ﬁnding support a role for oxidant-activated PKG Iα in the
maintenance of health, oxidation of this kinase have also been observed
in the pathogenesis of cardiovascular disease. PKG Iα oxidation con-
tributed to sepsis-induced hypotension [11], as well as myocardial
stress-induced apoptosis [12] and cardiac hypertrophy resulting from
pressure overload induced by transverse aortic constriction [13]. Con-
sistent with cyclic guanosine monophosphate (cGMP) negatively reg-
ulating PKG Iα [14,15], scenarios in which this second messenger is
reduced, such as when NO is less bioavailable, may potentiate oxidation
of the kinase to perhaps causatively mediate dysfunction [12]. Con-
sistent with these ideas, pharmacological agents that elevate cGMP or
mice expressing C42S PKG Iα that is resistant to disulﬁde formation
[12,13] demonstrate cardioprotection.
Obesity is associated with endothelial dysfunction, leading to re-
duced levels of NO and consequentially cGMP, which may causatively
manifests as impaired blood vessel relaxation and hypertension [16].
The lower levels of NO is thought to be signiﬁcantly mediated by ‘un-
coupling’ of NO synthase (NOS) resulting from depletion of cofactors
such as tetrahydrobiopterin (BH4) [17]. Such uncoupling is further
exacerbated by the concomitant accumulation of BH2 competing with
BH4 for its NOS binding site, resulting in superoxide production
[17,18]. Dismutation of superoxide to hydrogen peroxide (H2O2) can
oxidise and so activate PKG Iα via disulﬁde formation. Consistent with
this, obesity results in eNOS uncoupling in mice [19], and oxidative
stress in humans [20]. Oxidative stress can also promote eNOS un-
coupling by an additional mechanism involving S-glutathionylation of
its reductase domain [21]. Thus NOS uncoupling has a two-fold, sy-
nergistic impact on PKG Iα oxidation. This is because uncoupling not
only results in an elevation in oxidants that may target the kinase, but
the associated loss of NO will lower cGMP levels that otherwise nega-
tively regulate PKG Iα disulﬁde formation.
Based on the considerations above, disulﬁde PKG Iα is likely to
occur during times of NOS uncoupling such as obesity, and because of
the important roles of this kinase in the cardiovascular system, its
oxidation is anticipated to have functional consequences that may or
may not be maladaptive. In the current study, we tested the rational
hypothesis that potentiated PKG Iα oxidation occurs in vivo during
scenarios in which NOS is uncoupled such as obesity, utilising a high fat
feeding as a model. We also performed complementary investigations
using well-established pharmacological agents to monitor oxidation of
the kinase in cell, as well as in vivo, models. By comparing the response
of transgenic knock-in (KI) mice expressing C42S PKG Iα, which is fully
resistant to inter-chain disulﬁde formation at cysteine 42, to wild-type
(WT) we sought to deﬁne the impact of obesity-induced PKG Iα oxi-
dative activation on cardiovascular function.
2. Materials and methods
2.1. Cell experiments and studies with eNOS uncoupling agents in mice
Cells were grown on 12-well plates in an incubator at 37 °C with a
95% O2:5% CO2 environment. Bovine aortic endothelial cells (BAECs)
that are constitutively deﬁcient in PKG Iα were transfected with WT or
C42S kinase DNA as described [12]. Once conﬂuent, BAECs and pri-
mary rat aortic smooth muscle cells (SMCs) were treated with metho-
trexate (MTX, Santa Cruz Biotechnology, UK), 1,3-Bis(2-chlor-
oethyl)−1-nitrosourea (BCNU), 2,4-diamino-6-hydroxypyrimidine
(DAHP), NG-monomethyl-L-arginine acetate salt (L-NMMA) or H2O2 (all
from Sigma, UK) for 3 or 6 h.
Immunoblotting analysis of the redox state of PKG Iαwas performed
as described previously [8,11,22] with maleimide (100 mM) used in
preparation buﬀers to alkylate thiols and so limit thiol disulﬁde
exchange. Antibodies used in these studies included cGKIα (E-17; Santa
Cruz Biotechnology) or PKG antibody (ADI-KAP-PK005; Enzo Life Sci-
ence). Horseradish peroxidase–linked secondary antibody (Dako) and
ECL reagent (GE Healthcare) were used. Digitized immunoblots were
analysed quantitatively with a Gel-Pro Analyzer 3.1.
All procedures were performed in accordance with the Home Oﬃce
Guidance on the Operation of the Animals (Scientiﬁc Procedures) Act
1986 in the UK. C42S PKG Iα KI mice constitutively expressing PKG Iα
Cys42Ser were generated by Taconic Artemis and maintained on a
C56BL/6 as described before [8,11,22]. Only male mice were used in
the study. In some experiments, age and body-weight matched C56BL/6
male mice were purchased from Charles River, UK. Animals had ad
libitum access to standard chow and water and were kept in a speciﬁc
pathogen-free conditions under a 12-h day/night cycle at 20 °C and
60% humidity. DAHP (10 mM) was administered in the drinking water
of C57BL/6 mice (n = 4/group) for 3 weeks. The water containing
DAHP was refreshed every other day. At the end of the protocol, mice
were euthanized and hearts and vessels were collected for measurement
of the redox status of PKG Iα as described above. In a separate set of
experiments C57BL/6 mice were implanted with radiotelemetry trans-
mitters (as described below) and blood pressure was measured for three
days to establish the baseline, after which DAHP was administered in
the drinking water for a further 3 weeks. In an additional set of ex-
periments, WT or KI mice were given DAHP in their drinking water for
6 weeks, monitoring cardiac function by non-invasive echocardio-
graphy, as described below, basally before the drug treatment and then
at 1, 3 and 6 weeks afterwards.
2.2. High fat feeding study in mice
Age and body-weight matched WT or KI male mice were employed
in this study. WT or KI male mice were fed a control diet of standard
chow pellets after weaning (n = 10/group) and had ad libitum access
to water throughout the study. At the age of 10 weeks mice were im-
planted with radiotelemetry transmitters, as described below, and then
kept in individual cages enabling long-term acquisition of telemetric
data, as well as accurate measurement of body weight and food intake.
After the baseline cardiovascular parameters were recorded, WT or KI
mice were chronically administered a control RM3 (Special Diet
Services, UK) or high fat (RM 60% AFE, catalogue number 824054, LBS
Serving Biotechnology Ltd, UK) diet, on a random basis (n = 5/group).
This food was provided ad libitum in sturdy clear glass 60 ml re-
ceptacles with a purpose-drilled hole in the middle of the cap (Suppl.
Fig. 1), designed to limit the spillage of food so that consumption could
be accurately recorded. The control RM3 diet was ground, so to phy-
sically resemble the high fat diet, and was provided in an identical way
as the high fat diet, with content of the containers replaced at least
twice a week.
The RM 60% AFE diet consisted of 20% protein, 20% carbohydrate
and 60% fat, whereas the regular chow RM3 diet comprised 20% pro-
tein, 70% carbohydrate and 10% fat. Body weight was recorded weekly
for 16 weeks, after which measurements were performed on a fort-
nightly basis. Food intake was measured randomly at three time points
at the beginning, middle or the end of the study. At the end of the
feeding protocol, mice were anesthetized and subjected to the terminal
non-invasive echocardiographic measurement of their cardiac function
as described below. After completion of echocardiography imaging,
mice were euthanized and blood was rapidly sampled from the inferior
vena cava and immediately analysed for sodium (Na+), chloride (Cl-)
and blood urea nitrogen (BUN) using an iSTAT blood biochemistry
analyzer with EC8+ iSTAT cartridges (Abaxis, UK). The remaining
blood was centrifuged and the plasma was stored at −80 °C until fur-
ther analysis.
Hearts, aortae and the primary fat depositories were subsequently
harvested. The wet mass of the peritoneal, mesenteric, perirenal and
epidydimal fat tissues was measured to index total body adiposity. The
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heart and aortic tissue were frozen for subsequent analysis of PKG Iα
redox state, as described above.
Plasma content of obesity-related hormones (insulin, glucagon,
glucagon-like peptide-1, GLP-1, resistin, ghrelin, gastric inhibitory
polypeptide, GIP) and adipokines (leptin and plasminogen activator
inhibitor-1, PAI-1) was measured using a suspension bead array im-
munoassay kit following the manufacturer's instructions (Bio-Plex Pro
Mouse Diabetes Assay, Bio-Rad) using a Bio-Plex MAGPIX Multiplex
Reader (Bio-Rad). In addition, the amount of cGMP content was mea-
sured in plasma and aortae, using an Biotrak Enzyme immunoassay
(RPN226, GE Healthcare) as before [12]. Brieﬂy, aortae were snap-
frozen and homogenized in cold 6% trichloroacetic acid on ice. Aliquots
were centrifuged at 2000g for 15 min at 4 °C, and the pellet was dis-
carded. The supernatant was washed 4 times with ﬁve volumes of
water-saturated diethyl ether. The remaining aqueous extract was lyo-
philized and then dissolved in the manufacturer's assay buﬀer prior to
analysis following the acetylation EIA procedure as outlined in the
manufacturer's instructions. Plasma was diluted (1:10) in the manu-
facturer's assay buﬀer prior to analysis following their instructions.
2.2.1. Telemetric measurements
Blood pressure, heart rate (HR) and locomotor activity were as-
sessed by invasive radiotelemetry in conscious freely moving mice as
before [8,11,22]. In brief, mice were anesthetised with 2% isoﬂurane
(Centaur Services) in 0.5 l of oxygen per minute with peri-operative
analgesia (methadone, 1 mg/kg of body mass, Comfortan, Dechra, UK).
A TA11PA-C10 probe catheter (Data Science International, St Pauls,
MN, USA) was implanted into the aortic arch via the left carotid artery.
Following 7 days of recovery, mice were placed above the telemetric
receivers and the blood pressure, HR and locomotor activity was re-
corded by scheduled sampling for 10 s every 5 min. In each telemetry
study baseline data was collected for 3 days before the interventions.
During the high fat feeding study, the telemetry data was acquired each
weekend for the ﬁrst 16 weeks, after which is it was collected fort-
nightly until week 23 when the battering the probes expired.
2.2.2. Echocardiography
Telemetered (high fat feeding study) or non-telemetered (DAHP
study) mice were anesthetised with 2% isoﬂurane in 0.5 l of oxygen per
minute and examined by echocardiography using a non-invasive high
resolution Vevo 770 echocardiography system (RMV707B,
VisualSonics, Toronto, ON, Canada) with a RMV-707B transducer
running at 30 MHz. The core body temperature was maintained at 37 °C
with a feedback-regulated body temperature probe. High resolution,
two-dimensional B-mode and M-mode images were obtained at the
level of the papillary muscles and further analysed oﬄine with Vevo
Software (VisualSonics) as before [11].
3. Results and discussion
3.1. Uncoupling of NOS in vitro causes PKG Iα disulﬁde dimerization
The eﬀect of NOS uncoupling on PKG Iα disulﬁde dimerization was
tested in cell culture studies. BCNU treatment caused PKG Iα disulﬁde
dimerization in both cultured bovine aortic endothelial cells (BAECs)
transfected with WT PKG Iα construct (Fig. 1A) and rat aortic smooth
muscle cells (SMCs) (Fig. 1B). This is consistent with BCNU being an
inhibitor of glutathione reductase, which could lead to elevated glu-
tathione disulﬁde with consequent uncoupling by causing S-glutathio-
lation of NOS [21,23] via a disulﬁde exchange reaction. However it
should be considered that BCNU, also known as carmustine, has limited
selectivity [24], which is consistent with its being a small di-alkylating
agent that will react promiscuously with many protein thiols it en-
counters. Thus, it is diﬃcult to be conﬁdent of the precise mechanism
by which PKG Iα oxidation may have occurred after exposure to BCNU.
DAHP also induced PKG Iα disulﬁde dimerization in BAECs and
SMCs (Fig. 1A-B), consistent with its activity as a GTP cyclohydrolase I
inhibitor [25]. GTP cyclohydrolase I mediates de novo synthesis of BH4,
which when limited uncouples NOS so that it instead of NO, generates
superoxide. The latter then dismutates to H2O2, which in turn can
oxidise PKG Iα. MTX, which inhibits the regeneration of BH4 from BH2
by dihydrofolate reductase [26,27], and so also uncouples NOS, simi-
larly caused PKG Iα oxidation. MTX-induced oxidation was only ob-
served in the endothelial but not the smooth muscle cells (Fig. 1, A-B),
with the underlying reason for this discrepancy being unclear. Exposure
of BAECs to L-NMMA did not increase PKG Iα disulﬁde dimerization
(Fig. 1A), which it may have been anticipated to by inhibiting NOS and
so reducing the abundance of NO and cGMP. As cGMP negatively
regulates the oxidation of PKG Iα [12,14] L-NMMA may lead to accu-
mulation of the disulﬁde form of the kinase. However, as inhibitors of
NOS may also limit superoxide and so H2O2 production [18], such in-
terventions may also limit a key mechanism of PKG Iα oxidative acti-
vation and explain the lack of an eﬀect by L-NMMA.
3.2. C42S PKG Iα KI mice are protected from a moderate cardiac
dysfunction induced by eNOS uncoupling
Since robust PKG Iα oxidation was observed after in vitro treatment
of BAECs or SMCs with DAHP, and taking into account studies reported
by others [25,28], this compound was selected for use in follow-up in
vivo studies. Mice were chronically administered DAHP in their
drinking water for 3 weeks, which induced oxidation of PKG Iα in their
hearts and aortae as anticipated (Fig. 2A). In contrast, we did not ob-
serve similar increases in kinase oxidation in the mesenteric resistance
vessels from the same animals (Fig. 2A). Although this result is in
consistent with the lack of acute or chronic alteration in mean arterial
pressure (MAP) that was observed (Suppl. Fig. 2), it contrasts with
previous observations in rats, in which DAHP increased blood pressure
acutely to generate a sustained hypertension [28]. DAHP also increased
blood pressure in FVB mice [25], and again although the reason a lack
of an eﬀect in our studies is unclear, we note that our C57BL/6 mice are
a diﬀerent strain. Blood pressure is mediated by the tone of resistance
blood vessels, and as such, it is notable that DAHP failed to induce
oxidation in mesenteries. The reason why PKG Iα oxidation was ob-
served in the aorta and heart, but not in mesenteries is unclear, espe-
cially as then kinase is more susceptible to oxidation in the smaller
vessels [14]. Although mesenteries are widely used in investigations of
blood vessel regulation, it is important to consider that as part of the
splanchnic vascular bed that their contribution to peripheral resistance
is minimal. Furthermore, these vessels are also signiﬁcantly regulated
by cyclic adenosine monophosphate and protein kinase A, a signalling
pathway that has not been assessed in this study. Whilst it would be
valuable to determine the redox state of PKG Iα in other blood vessels
relevant to peripheral resistance, such as skeletal muscle arterioles, this
is diﬃcult to achieve for technical reasons. Dissection and preparation
of these small vessels takes much longer than isolation of the aorta or
heart, making the redox state measurements of PKG Iα in such tissues
unreliable. Another consideration regarding the lack of an eﬀect of
DAHP on a blood pressure is that uncoupled NOS enzymes are thought
to be a source of H2O2 basally in resistance blood vessels and that it is
this, and not NO, that principally mediates blood vessel relaxation [29].
In this scenario, in which H2O2 is thought to signiﬁcantly mediate the
endothelium-derived hyperpolarization factor-dependent mechanism of
vasodilation that is a major mechanism of vasodilation in resistance
vessels and for blood pressure regulation [29–31], perhaps hyperten-
sion is not rationally anticipated as a result of NOS uncoupling.
Although DAHP had no impact on PKG Iα oxidation in mesenteric
blood vessels, it was eﬀective in inducing this change in the heart where
this event may have direct eﬀects on myocardial function or structure,
despite the lack of an eﬀect on blood pressure. Consequently, we then
treated WT or KI mice with DAHP and compared their cardiac structure
and function non-invasively using echocardiography, serially over 6
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weeks (Fig. 2B). Cardiac output gradually declined to ~21% and the
diastolic posterior wall thickness increased by ~47% by the end of the
6-week protocol in WT mice. In contrast, the KI mice showed no decline
in their cardiac output and developed only a small increase (~12%) in
the cardiac posterior wall thickness by the end of the protocol. These
diﬀerential functional changes between genotypes were also matched
by serial, time-dependent changes in cardiac mass measured by echo-
cardiography. These analyses showed that the C42S PKG Iα KI mice
were resistant to cardiac hypertrophy compared to WT, which was
further corroborated by measurement of the wet mass of the heart
Fig. 1. In vitro treatment of cells with NOS-un-
coupling drugs results in robust PKG Iα disulﬁde
dimerization. (A) Bovine aortic endothelial cells
(BAECs) treatment with BCNU, MTX or DAHP
(100 μM for 3 h) resulted in signiﬁcant increase of
PKG Iα disulﬁde dimerization, whereas treatment
with L-NMMA (100 μM for 3 h) did not. (B) Smooth
muscle cells (SMCs) treatment with BCNU or DAHP
(100 μM for 6 h) resulted in signiﬁcant increase of
PKG Iα disulﬁde dimerization, whereas treatment
with MTX (100 μM for 6 h) did not. A positive con-
trol, namely 100 μM H2O2 for 30 min, causes nearly
all PKG Iα to disulﬁde dimerise. n = 6–8/group.
Data represented as mean± SEM. *P≤ 0.05, **P≤
0.01 versus vehicle treatment.
Fig. 2. In vivo treatment with DAHP causes PKG Iα disulﬁde dimerization and adaptive cardiac structural and functional abnormalities. (A) Increase of PKG Iα disulﬁde dimerization in
heart or aorta, but not in mesenteric vessels from mice treated with DAHP (10 mM in the drinking water for 3 weeks). (B) Heart mass to tibia length ratio was lower in the KI mice
compared to WT after 6 weeks of treatment with DAHP. (C) Time-dependent changes in left ventricular (LV) mass, stroke volume, cardiac output and posterior wall thickness at the
baseline and during 1, 3 and 6 weeks of DAHP treatment in WT and KI mice. n = 6/group. Data represented as mean± SEM. *P≤ 0.05, versus vehicle treatment (A) or versus KI (B and
C).
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isolated (normalised to tibia length) at the end of the protocol (Fig. 2C).
Cardiac hypertrophy can result from hypertension, but as mentioned
above, DAHP did not increase blood pressure in these studies and so
therefore cannot underlie the hypertrophic growth of the myocardium,
which was attenuated in the KI. Consistent with our observation that
cardiac PKG Iα becomes oxidised upon exposure to DAHP, this com-
pound depressed myocardial function, which was also apparent when
isolated ventricular myocytes were studied [25]. However, as DAHP
also increased blood pressure in that study [25], direct eﬀects on
myocardial cells or those secondary to hypertension cannot be dis-
tinguished [25]. In this connection, it is notable that pressure overload
resulting from transverse aortic constriction increased PKG Iα oxidation
[13], as did exposure to doxorubicin [12] and that in each of these
studies the C42S PKGIα KI mice were signiﬁcantly resistant to myo-
cardial structural and functional alterations induced by the intervention
in WT mice. A logical implication for these ﬁndings is that disulﬁde
PKG Iα formation in the heart is maladaptive, and this may be in part
because it contributes to stress-induced apoptosis [12], or prevents
interaction with the transient receptor potential channel 6 which can
mediate ant-hypertrophic signalling [13].
3.3. Obesity, PKG Iα oxidation and cardiovascular dysfunction
WT or KI mice were fed either a normal or a high fat obesogenic diet
for 27 weeks. The obesogenic diet progressively increased the mass of
the mice over time compared to those on a normal diet (Fig. 3A). In-
deed, this increase in mass was comparable between genotypes, as
measured at the ﬁnal 27-week time point (Fig. 3B). Food intake was
also similar between genotypes, albeit as anticipated mice consumed
less of the highly caloriﬁc high fat food compared to the normal chow
(Fig. 3C). Total body adiposity was estimated as a sum of peritoneal,
mesenteric, peri-renal and epidydimal wet fat mass after 27 weeks of
either diet and compared between genotypes (Fig. 4A). There was a
similar increase in total body fat after 27 weeks of high fat feeding in
WT and KI mice (Fig. 4B-C); although there is an insigniﬁcant trend
towards exacerbated adiposity in the KI mice fed a normal diet. Overall,
it was evident that the high fat diet induced obesity in the mice as
expected. It is of note that transgenic mice overexpressing PKG I ex-
posed to a high fat diet for 16 weeks were resistant to mass and
adiposity gain, although this only occurred in females but not in male
mice [32].
Blood pressure, HR and activity were compared in WT and KI mice
using radiotelemetry over the 23 weeks of high fat feeding (Fig. 5A-C).
Monitoring for a longer duration was precluded by the expiration of the
battery in the telemetric probes. A moderate but transient MAP increase
was observed in the WT mice peaking around 6, 10 and 23 weeks of the
high fat diet protocol (Fig. 5A). Analysis of the average MAP over the 23
weeks revealed that there was a trend for this to be higher in the WT
mice fed a high fat diet compared to the KI (Fig. 5D), although this just
failed to reach signiﬁcance at the 5% level (p = 0.08). KI mice were
basally hypertensive compared to the WT whilst on a normal diet
(Suppl. Fig. 3), consistent with earlier studies [8,22]. However, when KI
mice were switched to the high fat diet their blood pressure did not
increase, indicating a diﬀerential response compared to the WT
(Fig. 5D). The average HR decline was similar in both WT and KI mice
fed a normal diet over the 23-week period, possibly due to an active
baroreﬂex function serving to buﬀer blood pressure increases caused by
age. This decrease in HR was less prominent with the high fat feeding,
although no diﬀerences were observed between the WT and the KI
mice. Analysis of the average locomotor activity over the 23 weeks
revealed a strong trend toward a sedimentary life-style associated with
obesity; notably there was a more pronounced decrease in activity in
the KI mice fed a high fat diet compared to the WT mice.
At the end of the 27 weeks of high fat feeding the structure and the
function of the heart was assessed by echocardiography (Fig. 6A-B).
There was a trend towards a lower stroke volume and cardiac output in
the KI compared with the WT mice fed a normal diet. Although it failed
to reach signiﬁcance, this is in line with the previously published data
for younger mice [8,12]. KI mice fed a normal diet had smaller left
ventricular diastolic dimension and volume than the WT mice on a
normal diet, consistent with the diastolic dysfunction observed in the KI
mice previously [8,10]. The obesogenic high fat diet caused both sys-
tolic and diastolic dysfunction in the WT mice (Fig. 6B) which agrees
with other studies [6] and could result from a mild hypertension ob-
served in the WT mice. Such cardiac dysfunction was not observed in
the KI (Fig. 6B); again, in line with the lack of hypertensive response to
high fat feeding in the KI mice. The plasma levels of Na+, Cl- and blood
urea nitrogen (BUN) were increased in the WT mice fed a high fat diet,
Fig. 3. High fat feeding results in similar body
weight gain and food intake in WT and KI mice. (A)
Changes in body mass during 27 weeks of control or
obesogenic diet in WT or KI mice (B) Higher body
mass and similar heart mass in the WT or KI mice
after 27 weeks of feeding with high fat obesogenic
diet (grey bars) versus normal diet (white bars). (C)
Food intake measured at the beginning, middle and
before the end of the experiment in WT and KI mice
fed a control (white bars) or an obesogenic diet (grey
bars). n= 5/group. Data represented as
mean± SEM. *P ≤ 0.05 versus normal diet.). nd –
normal diet, od – obesogenic high fat det.
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but not in the KI mice (Fig. 6C), which may represent mild renal dys-
function in the transgenic. Such dysfunction might explain why MAP
increased by 8.0±2.6 mmHg in the high fat fed WT mice, whilst it only
increased by 1.8± 0.4 mmHg in the KIs (Fig. 5D). The less pronounced
changes in the KI mice are perhaps due to their smaller pressure re-
sponse than in the WT. A trend towards higher BUN in the KI fed a
normal diet could be age-related, although we previously reported si-
milar renal function in healthy young (12-weeks old) WT and KI mice
Fig. 4. High fat feeding has a similar eﬀect on adiposity in WT
and KI mice. (A) Mesenteric, perirenal and epidydimal fat to body
weight ratio are signiﬁcantly increased after 27 weeks of feeding
with obesogenic diet (grey bars) versus mice fed a normal diet
(white bars); (B) total body fat and (C) total fat to body weight
ratio are similarly increased in WT and KI mice after 27 weeks on
obesogenic diet. n= 5/group. Data represented as mean±SEM.
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 versus normal diet; #P ≤
0.05 versus WT.). nd – normal diet, od – obesogenic high fat det.
Fig. 5. High fat feeding has a mild eﬀect on blood pressure. (A-C) Mean Arterial Pressure (MAP), Heart Rate (HR) and locomotor Activity changes in WT and KI mice fed with a normal
diet (white marker types) or an obesogenic (grey marker types) diet for 23 weeks. (D) Delta response in MAP, HR and Activity in WT and KI mice after feeding with obesogenic diet (grey
bars) for 27 weeks, compared to the normal diet (white bars). n=5/group. Data represented as mean± SEM. *P≤ 0.05 versus normal diet.). nd – normal diet, od – obesogenic high fat
det.
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[8].
The amounts of leptin, resistin and glucagon in plasma were ro-
bustly increased in both WT and KI mice fed a high fat diet (Suppl.
Fig. 4) compared to the animals consuming a normal diet. An increase
in ghrelin and GIP was only observed in the plasma of WT mice fed a
high fat diet, while GLP-1 was only increased in the plasma of high fat
fed KI mice. There was a strong trend towards an increased level of
insulin and PAI-1in the plasma of both genotypes (Suppl. Fig. 4).
Consistent with this, albeit insigniﬁcant, trend towards higher basal
adiposity in the KI mice (Fig. 4), we also observed increased plasma
ghrelin, insulin, resistin, glucagon and GIP in the KI compared with the
WT mice fed a normal diet. Taken together, these data are in ac-
cordance with studies showing metabolic syndrome can be induced in
mice on a high fat diet [33]. Although plasma lipid proﬁling was not
performed, it is envisaged that the higher body mass and increased
adiposity in mice with a high fat diet, together with their elevated
circulating leptin levels would likely be associated with accumulation
of triglycerides, often characteristic of metabolic syndrome [33].
The plasma levels of cGMP were not altered in WT or KI mice fol-
lowing high fat feeding; however, there was a decrease of cGMP level in
the aortae of WT and KI mice fed a high fat diet, compared to those fed
a normal diet (Suppl. Fig. 5). This is consistent with NOS uncoupling in
the vasculature following high fat feeding. eNOS uncoupling was pre-
viously reported in vessels from obese db/db mice with features of type
2 diabetes [34], as well as in perivascular adipose tissue of mice fed a
high fat diet [19]. However, the loss of cGMP is not a conclusive evi-
dence of NOS uncoupling, as other mechanisms, such as phosphodies-
terase 5 activation or soluble guanylate cyclase inhibition, could also
decrease the production cGMP. For example, modulation of the soluble
guanylate cyclase redox state can alter its activity resulting in pertur-
bations of cGMP levels in the vasculature [35].
The level of PKG Iα disulﬁde dimer was similar in the hearts of WT
mice fed either normal or a high fat diet (Fig. 6D). This was unexpected,
because of the previous observation of increased PKG Iα oxidation and
moderate functional and structural cardiac changes in a model of
chronic NOS uncoupling with DAHP. Although our measurement of the
redox state of PKG Iα was made at the end of the protocol after 27
weeks of high fat feeding, it is plausible that earlier sampling may have
yielded diﬀerent results. Lack of PKG Iα oxidation following high fat
feeding in the heart tissues is not in agreement with the reduced level of
cGMP in the vasculature, although it was not possible to perform
complementary measurements of PKG Iα disulﬁde dimerization in the
aortae. There is a complex relationship between cGMP and oxidation of
PKG Iα. Whilst cGMP binding attenuates inter-disulﬁde formation [14],
how this oxidation potentially modulates cyclic nucleotide binding re-
mains unclear. Although signiﬁcant crystallographic information is
available for PKG [36–38], the structural impact of cGMP binding or
oxidation on the holoenzyme remains to be elucidated. Protein
Fig. 6. High fat feeding has no eﬀect of PKG Iα disulﬁde dimerization. (A) Similar left ventricular (LV) mass, stroke volume, cardiac output and posterior wall thickness in WT and KI mice
after feeding with obesogenic diet (grey bars) for 27 weeks. (B) Smaller LV systolic and diastolic dimension and volume in WT mice fed an obesogenic diet, compared to the KI. (C) Blood
concentration of sodium (Na+), chloride (Cl-) and blood urea nitrogen (BUN) in WT and KI mice after feeding with obesogenic diet (grey bars) for 27 weeks, compared to the normal diet
(white bars). (D) Feeding mice with high fat obesogenic diet for 27 weeks did not result in increase of PKG Iα disulﬁde dimerization in heart. n= 5/group. Data represented as
mean± SEM. *P ≤ 0.05 versus normal diet.). nd – normal diet, od – obesogenic high fat det.
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expression levels of antioxidant enzymes superoxide dismutase (SOD)
1, 2 and 3 in the hearts were not altered following high fat feeding in
either genotype. Interestingly, the levels of hyperoxidised (sulﬁnated or
sulfonated) peroxiredoxin protein were increased in the hearts of WT,
but not KI, mice fed a high fat diet. Hyperoxidised DJ-1 was not altered
in either genotype on either of the two diets (Suppl. Fig. 6).
Whilst mice exposed to high fat feeding clearly developed metabolic
syndrome-like symptoms, the impact on the cardiovascular system in
terms of hypertension or impaired cardiac performance was negligible.
This was unexpected, as hypertension has been observed with a similar
high fat feeding model in mice [39]. Of note, a high fat diet impaired
cardiac contractility in Drosophila [40] and mice [41]. The lack of the
cardiac structural changes after high fat feeding agrees with the lack of
increased PKG Iα disulﬁde dimerization in the hearts of WT mice on a
high fat diet. Perhaps a more severe dietary insult, such as prolonged
high fat feeding combined with high sucrose or fructose, might have
resulted in a more pronounced biochemical and cardiovascular phe-
notypical alterations. In addition, we cannot rule out a potential con-
tribution of the adenylate cyclase-cyclic adenosine monophosphate-
protein kinase A pathway which could be diﬀerentially modulated in
the in vivo models we employed.
In summary, we observed robust PKG Iα oxidation in vascular cells
treated with drugs that uncouple NOS. Uncoupling of NOS in vivo also
induced PKG Iα oxidation in aorta and hearts and was associated with
moderate cardiac structural and functional abnormalities in WT mice,
with the KIs being protected from such changes. These observations are
in line with previous studies reporting an injurious role for PKG Iα
disulﬁde dimerization in the setting of chronic myocardial oxidative
stress. In contrast, there was no evidence of PKG Iα oxidation in the
hearts of the WT mice chronically exposed to a high fat diet. We con-
clude that despite robust in vitro evidence of PKG Iα disulﬁde dimer-
ization under conditions of NOS uncoupling treatments, it is likely that
oxidation of this kinase plays a neutral role in cardiovascular adapta-
tion triggered by a diet-induced obesity.
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